Purchase Order 75N93024P00162
Award Date 12/19/23
Potential Completion Date 3/31/24
Potential Value $12K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- BD Biosciences, a division of Becton, Dickinson and Company, has been awarded a firm fixed price purchase order valued at eleven thousand nine hundred fifty-two dollars and four cents ($11,952.04) by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for service of BD flow cytometers and lasers to support the agency's biomedical research programs. Performance will take place in San Jose, California through February 2024. No set-aside...
- Becton, Dickinson and Company (BD), operating through its BDB Division as BD Biosciences, was awarded a purchase order valued at $24,924.63 by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD), a component of the National Institutes of Health. The contract, awarded on December 30, 2025, covers a period of performance from December 29, 2025, through July 16, 2026, with an ultimate completion date of July 17, 2026. The award encompasses service contracts for...
- Becton, Dickinson and Company, operating through its BD Biosciences division, was awarded a $13,883.23 firm fixed-price purchase order by the National Institute of Allergy and Infectious Diseases (NIAID) on March 10, 2022, with a completion date of April 30, 2022. The contract covers pre-contract inspection and recertification services for an LSR Fortessa flow cytometry system, a critical research instrument used in biomedical analysis and infectious disease research. The work is to be performed...
- BD Biosciences has been awarded a firm fixed price purchase order totaling $73,666.80 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract has no set-aside designation. BD Biosciences will provide various flow cytometers, lasers, and associated equipment in support of biomedical research being conducted by the agency. Specifically, the contract calls for BD BIOSCIENCES SYMPHONY S6 flow cytometers, FACSTATION cell sorters, and various lasers...
- Becton, Dickinson and Company (BD Biosciences division) has been awarded a firm fixed price purchase order totaling $17,668.80 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The contract is for annual service of BD Biosciences' FACSCelesta flow cytometry system located in San Jose, California, with performance through March 1, 2025. No set-aside designation was used for this procurement. BD Biosciences will provide maintenance and support for the...
- The National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $335,730.01 firm fixed price purchase order to Becton, Dickinson and Company for one BD FACSymphony A3 Flow Cytometer and FACSFlow Supply System. The place of performance will be Becton, Dickinson and Company's Franklin Lakes, New Jersey facility and the period of performance is from September 20, 2022 through February 24,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Becton, Dickinson And Company (BD), a global medical technology company, a $56,980.44 firm-fixed-price purchase order contract for a Service Agreement for FAC Symphony, High Throughput Sampler and Lasers. The contract has an April 30, 2025 completion date and was awarded on May 1, 2024. BD, through its BD Biosciences division, provides instruments, reagents, and...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $346,392.00 firm-fixed-price purchase order to Becton, Dickinson And Company (BD) for maintenance and support of BD Biosciences Symphony S6 flow cytometers and lasers. The contract is for a base year from May 2022 to January 2023, with four one-year option periods, for a total potential value of up to $500,000 over five years. There is no...
- Becton, Dickinson and Company, through its BD Biosciences division, was awarded a Firm Fixed Price purchase order valued at $15,976.71 on May 10, 2025, by the National Institute of Allergy and Infectious Diseases (NIAID) to provide maintenance and service support for an LSR Fortessa flow cytometry system at the NIH facility in Bethesda, Maryland. This contract, which concludes on September 30, 2025, represents a component of the FY26 Unified Digital Operations (UDO) Initiative and was awarded...
- This is a $217,295.28 firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson and Company (BD) for a maintenance agreement covering BD Biosciences Symphony S6 and S5 flow cytometry instruments. The award is a follow-on to a request for quotes (RFQ) under simplified acquisition procedures and is not set aside for small businesses. BD, a global medical technology company, is the prime...